NCT00197756

Vitamins, Breastmilk HIV Shedding, and Child Health

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 771 (actual)
• Sponsor: Harvard School of Public Health (HSPH) · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to analyze stored samples and data collected during the conduct of the study "A Trial of Vitamins in HIV Progression and Transmission" (HD32257). The aims are to examine the effect of vitamin supplementation on HIV infected women during pregnancy on a number of parameters in breastmilk.

Detailed description

The purpose of this study is to analyze stored samples and data collected during the conduct of the study "A Trial of Vitamins in HIV Progression and Transmission" (HD32257). The aims are to examine the effect of vitamin supplementation on HIV infected women during pregnancy

Conditions

• Maternal and Child Health Outcomes

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Vitamin A alone	30 mg beta-carotene plus 5000 IU preformed vitamin A) taken orally once per during pregnancy and lactation
DIETARY_SUPPLEMENT	Multivitamins excluding vitamin A	30 mg thiamine, 20 mg riboflavin, 20 mg B-6, 100 mg niacin, 50 ug vitamin B-12, 500 mg vitamin C, 30 mg vitamin E, 0.8 mg folic acid taken orally once per day during pregnancy and lactation
DIETARY_SUPPLEMENT	multivitamins including vitamin A	20 mg thiamine, 20 mg riboflavin, 25 mg vitamin B6, 100 mg niacin, 50 ug vitamin B12, 500 mg vitamin C, 30 mg vitamin E, and 0.8 mg folic acid taken once per day orally during pregnancy and lactation
OTHER	Placebo	Placebo pill taken orally once per day during pregnancy and lactation

Timeline

• Start date: 2004-09-01
• Primary completion: 2007-08-01
• Completion: 2007-08-01
• First posted: 2005-09-20
• Last updated: 2009-08-21

Locations

1 site across 1 country: United States